Wednesday, Sep 17th
Last update07:13:23 AM GMT
Drug companies are blocking or delaying the entry of cheaper generic medicines into the EU, pushing up medicine bills, the European Commission has said.
Their actions cost EU healthcare providers 3bn euros ($3.9bn; £2.5bn) in savings between 2000 and 2007, it said.
 The disruptions were also sex-specific — affecting donor liver cells of males and females in different... |
 A measure that would allow Texas residents to sue out-of-state abortion pill providers advanced to the... | ||
 Throughout the last two years, Gaza has faced widespread destruction as a result of Israel’s ongoing... |
 The U.S. is seeing a late summer surge in COVID-19 cases, tracking from the Centers for... |
